Egg Protein Market to Witness Significant Growth due to Rising Concern About Nutrition Among Consumers by 2022 | Million Insights

Global egg protein industry is expected to rise at a higher CAGR in the global market since eggs cater to the muscle needs of the body and is also a rich source of amino acids. Egg provides dense nutrition such as Vitamin B, riboflavin, folate, B12 and B6 needed essentially for the body growth. Hence, high-quality proteins ensure valuable contribution in synthesizing and maintaining muscle power coupled with regulation of blood glucose level.

Commercially, the availability of dietary protein is extensively considered to be essential to enhance optimal lean muscle growth while sessions of strength training. Researchers and trainers commonly agree upon proteins are building blocks of muscle and necessary for muscle to grow and repair. Intake of adequate amounts of dietary protein while training can help in facilitating and support movements of strength. Eggs offer all 9 essential and 9 non-essential amino acids termed as 'EAA'. Thus, the presence of all 18 essential and non-essential amino acids constitutes a high-quality egg protein. Overall, with the growing concern for healthy nourishment and muscle fitness, the global egg protein industry is expected to rise at a higher CAGR in the forecast period.

Global egg protein industry is driven by factors such as rising concern for nutrition among consumers. Additionally, egg protein is being invigorated for food & beverage products such as bakery, meats, ice-creams and sport foods. Moreover, growing emphasis on fitness by consumers and growth in protein consumption as an essential nutrition is expected to drive the global market in the forecast period.

Sources such as egg, soy, whey, beef and pork comprise a higher protein proportion and rising demand for such products is anticipated to drive the global market in the assessment period. However, the growing consumption of red meats such as pork and beef along resulting into intake of high protein content is expected to impede the market growth.

Global egg protein industry is segmented into egg white powder, whole egg powder and egg yolk powder, based on product. Based on end-user, the global egg protein is segmented into bakery, meat product and ice cream.

Based on geography the global egg protein industry spans North America, Latin America, Europe, Asia-Pacific, Middle East. Asia-Pacific regions are anticipated to grow at a higher CAGR in the forecast period owing to rise in consumer awareness towards nutritional foods. Also, the trajectory rise in poultry production in Indian market boosts the availability of eggs in the market. Europe and North American regions are also expected to grow in the forecast period. Middle East and African regions are also expected to grow in the forecast period owing to growth in consumer awareness towards nutritional foods.

The key players in the global egg protein industry include Sanovo, IGRECA, Bouwhuis Enthoven, BNL Food, Interovo, Eurovo Group, Rose Acre Farms, Avangardco, VH Group, Wulro, A.G. Foods, Farm Pride, GF Ovodry, Post Holdings, SOVIMO HELLAS, Rembrandt, Dalian Hanovo Foods, DEB EL FOOD, Lodewijckx Group, Kewpie, Dalian Lvxue, Kangde Biological, Jinlin Houde, and Etam Biological Polytron Technologies.

Read More

FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices

The U.S. Food and Drug Administration today permitted marketing of the Dexcom G6 integrated continuous glucose monitoring (iCGM) system for determining blood glucose (sugar) levels in children aged two and older and adults with diabetes. This is the first type of continuous glucose monitoring system permitted by the agency to be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Today's authorization also classifies this new type of device in class II and subjects it to certain criteria called special controls. This enables developers of future iCGM systems to bring their products to market in the least burdensome manner possible.

"The ability of this device to work with different types of compatible devices gives patients the flexibility to tailor their diabetes management tools to best meet personal preferences," said Donald St. Pierre, acting director of the Office of In Vitro Diagnostics and Radiological Health in the FDA's Center for Devices and Radiological Health. "In addition, the FDA has taken steps to expedite the review process for similar, integrated CGMs and make these types of systems available to patients as quickly as possible while also helping to ensure their safety and reliability."

Nearly 10 percent of Americans have diabetes, which impairs the body's ability to make or properly use the blood glucose-regulating hormone insulin. They must regularly monitor their blood sugar levels since continuously high blood sugar levels can lead to heart disease, stroke, blindness, kidney failure and nerve damage leading to amputation of the toes, feet or legs. Blood sugar levels can also fall too low, which can cause dizziness, confusion, unconsciousness and, in extreme cases, death.

Continuous glucose monitoring systems that were first marketed had a different intended use and were evaluated through the FDA's premarket approval pathway, the most rigorous review designed for the "highest risk" class III medical devices. However, the Dexcom G6 system is intended for a more seamless integration with other diabetes devices, and the FDA recognized this as an opportunity to reduce the regulatory burden for this type of device by establishing criteria that would classify these as "moderate risk" class II medical devices with special controls. With the authorization of the Dexcom G6, future iCGMs that meet the special controls criteria can go through a more streamlined premarket review known as 510(k) clearance.

The Dexcom G6 is a patch device, about the size of a quarter, that is applied to the skin of the abdomen and contains a small sensor that continuously measures the amount of glucose in body fluid. The device transmits real-time glucose readings every five minutes to a compatible display device such as a mobile medical app on a cell phone and will trigger an alarm when a patient's blood sugar enters a danger zone soaring too high or dropping too low. If it's integrated with an automated insulin dosing system, a rise in blood sugar would trigger the release of insulin from the pump. The patch device should be replaced every 10 days.

An earlier generation of the technology, the Dexcom G5 system, received FDA approval in 2016 but was not designed as an integrated system to be used with compatible devices. Unlike the earlier model, the Dexcom G6 version is factory calibrated and does not require users to calibrate the sensor with fingerstick blood glucose measurements. In addition, it has an updated sensor probe that minimizes interference with the pain reliever acetaminophen.

The FDA evaluated data from two clinical studies of the Dexcom G6, which included 324 adults and children aged 2 years and older with diabetes. Both studies included multiple clinical visits within a 10-day period where system readings were compared to a laboratory test method that measures blood glucose values. No serious adverse events were reported during the studies.

Risks associated with use of the system may include hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) in cases where information provided by the device is inaccurate and used to make treatment decisions or where hardware or set-up issues disable alarms and alerts. Patients may also experience skin irritation or redness around the device's adhesive patch.

The FDA reviewed data for the device through the de novo premarket review pathway, a regulatory pathway for novel, low-to-moderate-risk devices that are not substantially equivalent to an already legally marketed device. Along with this authorization, the FDA is establishing criteria, called special controls, which outline requirements for assuring iCGM devices' accuracy, reliability and clinical relevance as well as describe the type of studies and data required to demonstrate acceptable iCGM performance. These special controls, when met along with general controls, provide reasonable assurance of safety and effectiveness for this device. 

Read More

Colgate Bright Smiles, Bright Futures Educational Program and The Sloane Stephens Foundation Serve Up Smiles to America's Youth

The Colgate Bright Smiles, Bright Futures educational program has partnered with The Sloane Stephens Foundation to instill healthy habits among America's underserved youth through a new initiative called "Serving Up Smiles." At select Foundation "play days," where children can practice tennis basics on a professional court with Stephens, the Colgate Bright Smiles, Bright Futures mobile dental van will be on-site to provide free oral care screenings for children ages three to 12, along with games and educational activities for all ages.

The National Institute of Health reports that tooth decay is the most common chronic disease in children, yet is also completely preventable with proper oral care habits. For many families without education about oral care or access to biannual professional dental visits, these healthy habits are often never formed.

Similarly, The Sloane Stephens Foundation — launched in 2013 by the tennis champion and her family — is dedicated to inspiring a love of physical fitness in children who often lack structured physical education in school. Together, these two organizations are dedicated to supporting children who need it most.

"Since I was young, I was given a love of tennis and physical activity – something that's always brought a smile to my face. I'm excited to partner with Colgate to educate the next generation about healthy habits, from exercise to tooth-brushing," Stephens said.

Individuals can help serve up, even more, smiles by sharing the campaign's their social media channels with the hashtag #ServingUpSmiles on or before August 15, 2018. For every share, Colgate will donate $1 to The Sloane Stephens Foundation to further support healthy habits among children¹.

Read More

Rehan Poncha and VJ Anusha create some excitement with Speedo

Speedo, the world's leading swimwear and Swim Accessories brand launched a range of innovative work out gear designed for women to wear both in and out of the water, the collection is called Speedo H2O Active. Made with the modern fitness enthusiast in mind, H2O Active is designed for both water and land based workouts.

Speedo is helping you kick up your fitness a gear with H2O Active and recently hosted a water based fitness class called FloatFit in collaboration with AquaPhysical.

Celebrities who are fitness freaks like Anusha Dandekar and Rehan Poncha who took part in this activity visited the Speedo Store at Phoenix MarketCity Pune at Viman Nagar to curate their fitness gear and prep-up for the intense water workout.

"I got a chance to train in the pool and be part of the exciting Floatfit® class in the newly launched Speedo H2O Active collection meant for both water and land workouts. It was fun and amazing. Exercise in water is such a fantastic equaliser – the harder you push, the harder the water pushes back! ... and, of course the other huge benefit is the low impact and therefore lower risk of injury,” said, actress and fitness enthusiast Anusha Dandekar.

Rehan Poncha who is Speedo’s Fitness Mentor said “Fitness is a way of life for me and it’s always fun to find innovative ways of working out. Aqua-fitness is becoming a rage in India.  I enjoyed being part of Speedo’s excellent floatfit activity and feel it is really quite impressive and the best part is that just half an hour of working out in the water can be just as effective as an hour’s exercise on dry land.”

Anusha and Rehan, along with the bloggers were seen sharing their love for water to educate more people on the benefits of adding water to their workout regimen thereby inspiring them to jump in.

  

Read More

Ping An Technology again wins world-class award in medical field after setting new world record in LUNA rankings

The results of the Indian Diabetic Retinopathy Image Dataset (IDRiD) fundus analysis competition organized by the IEEE International Symposium on Biomedical Imaging (ISBI) were recently announced. Ping An Technology's PAMIA (Ping An Medical Imaging Assistant) performed head and shoulders above its peers, including a world first in EX (hard exudates) image segmentation, world second in HE (bleeding) segmentation and world third in MA (microaneurysm) segmentation task.

Ping An Technology again wins world-class award in medical field after setting new world record in LUNA rankings

This is the second time this year that Ping An Technology has garnered awards in a world-class competition in the medical imaging research sector, heralding another milestone for the company in artificial intelligence. Earlier in the year, PAMIA had set a new record for nodule detection with an accuracy rate of 95.1 percent, and beat its own previous record for false positive reduction with an accuracy rate of 96.8 per cent in the international authoritative Lung Nodule Analysis (LUNA) rankings for medical imaging.

ISBI is an international conference dedicated to biomedical imaging sponsored by the IEEE Signal Processing Society (SPS) and the IEEE Engineering in Medicine & Biology Society (EMBS). The competition attracted the participation of 22 well-known research and medical institutions, among them, iFlytek, Nanyang Technological University, National Tsing Hua University, Peking University and Samsung. The diabetic retinopathy (DRP) segmentation and classification challenge using the IDRiD dataset included three subsections: lesion segmentation, case classification and monitoring of the optic disc and central fovea. The subsection that the PAMIA platform participated in is the most difficult competition in terms of lesion segmentation and best reflects the strength of intelligent film reading.

DRP is one of the most common microvascular complications in diabetes, with a very high incidence of vision impairment including, in some cases, total blindness. Timely detection and treatment can greatly reduce the risk of vision loss, while early detection with an indication for treatment has important clinical significance. The three lesions, EX, MA and HE, are key to the diagnosis of DRP, in which EX is the main characteristic of the middle stage of the disease, while also signaling the critical time period for engaging in a treatment regimen. The detection and segmentation model for EX, HE and MA can be used to display the edge of the relevant lesions on the basis of classification prediction of DRP, assisting doctors in diagnosing and deciding on the best treatment options quickly. PAMIA ranks first worldwide when it comes to EX, the most difficult yet most important lesions segmentation challenge, while ranking among the top three globally for the segmentation of other lesions.

The fundus image is different from other image scenarios, as these lesions only occupy a few dozen pixels. PAMIA, in order to ensure the detection sensitivity, combined its comprehensive advantages in the field of medical diagnosis and deep learning with its experience of setting new world records in the LUNA competition at the beginning of the year to design a new segmentation network that used deep and transfer learning theories to identify suspected lesions quickly and achieve boundary segmentation. At present, the marking and segmentation of lesions can be completed in a few seconds, greatly improving the reading speed and accuracy rate.

Ping An Technology has achieved several milestones in the intelligent film reading field since 2016 when it entered the medical imaging sector. These achievements reflect the company's leadership and dominant position in the technologies related to medical imaging. With this award as a new milestone, PAMIA plans to devote itself to furthering its research on medical artificial intelligence, helping to achieve a strategic development goal for China's artificial intelligence sector.

Read More

Tyber Medical Announces the Limited Release of the Sterile Comprehensive Forefoot Procedure Kit

Tyber Medical, LLC, a privately held company focusing on developing innovative medical devices for private label opportunities and advancing the science of bioengineered surfaces, announces the limited release of the Forefoot Procedure Kit. 

Tyber Medical is excited to announce the limited release of the Forefoot Procedure Kit. This innovative system is the first efficiency kit on the market to incorporate room setup disposables, instruments for soft tissue, bone and implant preparation, and the corresponding implants. The system configuration allows for flexibility in the treatment of a wide range of fixation procedures including bunion corrections, hammertoes, Aikens as well as Weil's osteotomies. This unique one of kind system is provided sterile to increase efficiency in the Operating Room. 

The complete kit eliminates the necessity for cleaning, decontamination, sterilization, and reprocessing thereby reducing direct and indirect costs while accelerating room turnover to create a more efficient center.  All implants are sterile, ready-to-use, and include headed or headless screws, TyFix™ hammertoe screws, snap-off screws, as well as NiTiNOL staples in various sizes to suit any type of Forefoot procedure.    

Catye Mullens, a Certified Surgical Technician in Materials Management at Wilshire Surgery Center and a member of the design team stated, "The Forefoot Procedure Kit is a time saver for OR setups and comes with all the fundamental items we need and nothing we don't. We also appreciate the efficient space management design which minimizes shelf requirements for our surgery center."  Donna Faillace, a Certified Surgical Technician at Providence Health Center commented "The Forefoot Procedure Kit makes it so easy to set up for surgeries knowing everything our surgical team and center needs is included.  It decreases turnover time because you're not waiting for instruments to process and the surgeon is pleased because he has consistent equipment available for every case."

"The Forefoot Procedure Kit was designed to be an inclusive system delivering a procedure in a box while allowing the surgeon flexibility to create any type of Forefoot reconstructive procedure. The kit aligns efficiency and effectiveness together to offer a solution for cost reduction, time efficiencies, and better organization of pre-operative planning," commented Jeff Tyber, CEO of Tyber Medical.

Tyber Medical continues to focus on systems designed to drive pre-operative, intra-operative, and post-operative efficiency, while embracing system improvements that could lead to a lower rate of surgical field contamination and subsequent patient infections.  Please visit Tyber Medical's Booth #333, at ACFAS in Nashville, TN where the company will showcase the Forefoot Procedure Kit and recently released TyFix™ System as well as other innovative products available for private labeling.

Read More

Pharmaceutical Sector, Retailers & Distributors to go digital using Medipta App

The Maharashtra State Chemists& Druggists Association (MSCDA) & Medipta a medical services aggregator announced their collaboration in the city today. The MSCDA is encouraging & assisting the drug trade industry to promote the development of pharmaceutical sector. Medipta is India’s first such innovative app which connects patients, Doctors, Diagnostic labs and Chemists and every entity in healthcare industry.

Minister of State Food & Drug Administration Mr. Madan Yerawar officially launched Medipta in Mumbai today. Mr.Jagannath Shinde President of MSCDA was present during the moment &announced Medipta as a Technology Partner for all Chemists and Druggists around Maharashtra. While addressing media he said, ‘MSCDA intends to channelize the entire pharma logistics into organized manner which will minimize wastage, optimize operating cost and working capital. In collaboration with Medipta all chemists& druggists will become as organized force to strengthen present pharmacy retail chain. Through Medipta they will get opportunity to increase business by connecting people in the same field.’Online drug supply system is a major threat to all Retailers, Distributors & all allied Medical Services. Medipta will be aggregating all retailers to reach patients in 20 minutes over digital prescription and delivery management software, he added.

Through this collaboration, not only Stockists can supply medicines to chemists as per necessity, but Chemists/Pharmacists can also supply medicines to patients, doctors & maintain records of prescription. Chemists & Druggists can get advantage of stock inventory information on this app. Chemists can get reminder if medicines not delivered to patients on time.One app for 16 entities covering over 150 features in just 15mb space makes Medipta innovative. Other major benefits of Medipta app are Patients in need of any kind of medical guidance or treatment right from medicine reminder system with a pregnancy app too.

Doctors/ Hospitals/ Clinics can get access to patient’s information and guide them accordingly Test labs/radiologist/diagnostic centers can provide lab tests and diagnostic facilities to patients and upload reports online all the allied medical services like Labs, Blood Bank, PHCs, Ambulance and Insurance also can be availed through this platform.

Mr. Rahul Bojalwar, Founder and CEO of Medipta said, “Medipta Solutionsis a health care hub where anyone can come for e- health services. It’s the only app in India which connects every entity on one platform. It is connecting people with health experts to live a healthy life. By creating and perfecting a comprehensive healthcare platform we are setting up a new era in Healthcare. One important aspect of this app is its absolutely free for patients, doctors, ambulance and blood bank.’’

Read More

Shapiro+Raj Hires Gwen Costa to Lead West Coast Expansion

Shapiro+Raj, a leading strategic brand and marketing insights company, announced today that it has hired Gwen Costa as Senior Vice President to lead the organization's West Coast expansion.

Gwen joins Shapiro+Raj with more than 25 years of experience in the biotech and pharmaceutical industries. After an accomplished career in sales for companies including Merck, AstraZeneca and Tokos Medical Corporation, she moved into key positions at Baxter, as a global leader of the bioscience marketing division and at Amgen, as director of business analytics, marketing excellence and brand planning. After years on the client side of the business, Gwen brought her unique perspective to the market research world. In addition to developing the West Coast healthcare practice for Harris Interactive, she most recently served as Senior Vice President for AplusA Bella Falla. There she was responsible for driving growth, building strategic alliances and diversifying their client base.

"The Shapiro+Raj model is about connecting research and insights with brand strategy capabilities. Gwen personifies this model. She is a growth-minded research professional who has pharma experience that spans the entire product lifecycle. I can't think of anyone better to serve our rapidly growing West Coast client base," said Zain Raj, Chairman and CEO of Shapiro+Raj.

As Senior Vice President, Gwen will be responsible for establishing Shapiro+Raj West Coast operations as well as serving the company's clientele throughout California. 

"Shapiro+Raj has a strong reputation—particularly in the pharmaceutical industry—for uncovering insights that can solve problems and move businesses forward. As a former marketer on the client side, that's an exciting story to tell" said Gwen. "I look forward to being a part of the team and helping the company grow."

In addition to Gwen's professional credentials, she has developed curriculum and taught at the university level. Gwen holds an MS in neurophysiology from Penn State University and a BS in Health Science, Education and Psychology from Lock Haven University.

Read More

Sportina Exim Introduces ‘Promaxima’, Houstan Based Fitness Equipment In India.

Sportina will be representing Promaxima as a sole distributor for the Asian market

Sportina Exim Pvt. Ltd. has for over two decades benchmarked itself as a one-stop-shop for complete sports infrastructure requirement complying with the highest international quality standards that puts the company as a key leader in the industry. Sportina has now introduced ProMAXima, a Houston based company to India, who are the gym equipment manufacturers, having an experience of more than 45 years in CARDIO, STRENGTHENING & CROSS-TRAINING. Sportina will be representing as a sole distributor having exclusivity for Asian market.’

Announcing the launch, Henry Sheth, Director, Sportina Exim Pvt. Ltd. said, “For over four decades ProMAXima has been the most preferred name in the commercial fitness industry worldwide and we are proud to partner them for the Asian market. ProMAXima products are designed to meet rigorous quality standards, endless pursuit of innovation and commitment to customer satisfaction. SPORITNA will be presently targeting leading condos, hotels, gyms, health clubs, colleges, residential complexes and sports arenas nationally”.

For years Pro Maxima has been providing quality fitness equipment to the U.S. Army, US Navy, US Air-force, US Marines, US Coast Guard, FBI and CIA. ProMAXima’s professional design team help optimize the layout of the facility to ensure they get the equipment and results they desire in order to remain happy and healthy. Sportina’s mission is to increase sports awareness by developing sports infrastructure in schools, colleges, universities, clubs, private houses & sports stadiums for indoor - outdoor areas which would create deep fitness awareness in public & private sector pan India.

The commercial fitness market in India has seen exponential growth over the years due to various factors like introduction of new age gyms, fitness services, rising chronic health disorders and healthcare awareness programs. With rapid urbanization, rise in disposable income, technological advancement and changing lifestyle the gen next is dedicating more time on fitness with a firm penchant towards healthy living.

Read More

Now doctors will see you on Sunday’s also – Free consultation by Jupiter Hospital

Jupiter Hospital (Baner-Pimple Nilkh road, Baner. Pune-45) is organizing free consultation by MD Physician to support you in your hour of need for medical advice, we have arranged for doctors on every Sunday whom you may consult absolutely free.

·         Free consultation by MD Physicians

·         OPD time on Every Sunday between 10 AM to 6 PM

·         Medicines and Investigations are chargeable

·         30% discount on investigation

This OPD will be held between 10 AM to 6 PM for all patients. This department seeks to bridge the gap between the needy patients and the fast evolving medical technology. Although medicines and investigations will be chargeable but patients can seek advice and consultations from specialist physicians for free. From the following day, you can continue to visit your doctor for further consultation. Jupiter hospital is giving 30% discount on investigation.

The Sunday OPD is our way of giving back to the community with the best in medical advice and care. Jupiter Hospital thinks, social responsibility and the pursuit of societal good through inclusive healthcare inspired them towards fulfilling India’s colossal rural healthcare needs.

Read More

90% Indians Don't Sleep at the Right Time: Godrej Interio Study

A recent study conducted by Godrej Interio reveals that sleeping post 10 pm is clinically declared as the inappropriate time to go to sleep as it triggers a change in the sleeping pattern that leads to sleep deprivation. This is irrespective of the number of hours of sleep. The study was conducted across 8,000 Indians living across the metros in India. Godrej Interio, India's leading furniture brand in both home and institutional segments, launched the sleep@10 campaign last year that focuses on addressing the rising concern over sleep deprivation in India. Over 93% of Indians are sleep deprived.

     The study is based on the insights sourced from Indians that have taken their sleep test on the sleep-o-meter hosted on the sleep@10 website. Over 1.5 lacs Indians have taken the sleep test. Mumbai is found to be the most sleep deprived city in India. The survey also found that nine out of every ten respondents felt dull after they wake up. Around 64% of the respondents admitted that 'screen time', including television and phone, could be delaying their sleep time while 55% of the respondents said they slept after midnight while the ideal time would be around 10 pm. The study further revealed that the problem of not sleeping on time wasn't only restricted to adults but kids as well wherein only 90% of respondents below 18 years sleep after 10 pm leading to sleep deprivation on a rampant rise among the next generation.

Commenting on the research findings, Dr. Preeti Devanani, Sleep medicine specialist, Sleep@10 - A Godrej Interio initiative, said, "The time of night when you sleep makes a significant difference in terms of the architecture and quality of your sleep. The slumber is composed of a series of 90-minute cycles during which your brain moves from lighter stages to deep slow wave sleep which is a part of non-Rapid Eye Movement (non-REM) sleep and Rapid Eye Movement (REM) sleep, which is essential for memory formation and hormonal regulation. The cycle durations and percentages vary depending on the level of sleep deprivation as the brain has to compensate with recovery sleep and this may compromise quality and functions. Also, the addiction to technology and multiple devices all through the day and accessing them immediately before sleeping is also on the rise impacting the quality and duration of sleep. In this modern lifestyle, sleep deprivation is turning out to be a rising concern." 

Commenting on the Sleep@10 sleep-o-meter findings, Anil Mathur, COO, Interio Division, said, "We at Godrej Interio are committed towards health of the nation and Sleep at 10 is an initiative which promotes right sleeping habits which is beneficial for overall health and productivity. The sleep-o-meter study was conducted to create awareness about how sleep is becoming more critical from a health point of view - not just sleep, but the quality, the duration and the time when we go to sleep."

According to the sleep-o-meter data, collected by a survey conducted by Godrej Interio, the sleep@10 website reveals that for the respondents between 18-25 age group, 29 percent go to sleep between 12 midnight to 2 am while 58% rarely sleep at 10 pm which is an apt time to sleep. Amongst respondents between 26-54 age group, 36% get less than 6 hours of sleep while only 8% respondents are able to sleep at 10 pm. For the respondents above the age 55 years, 41% sleep after 10 pm but before 12 amwhile 40.4% rarely/never sleep at 10 pm.

Also, the data reveals representational region wise study with respect to respondents from metros, tier 2 and 3 cities. The insights garnered about Mumbai respondents from the research says that 95% very rarely sleep at 10 pm whereas 35% respondents sleep after 12 am and 34% sleep less than 6 hours. In Delhi, 72% respondents very rarely sleep at 10 pm whereas 14.36% sleep after 12 am and 30.4% sleep less than 6 hours. In tier 3 cities, only 13% respondents sleep at 10 pm whereas 35% sleep less than 6 hours while only 6% feel fresh and are ready to face the world after waking up. Prominent lifestyle changes in adults seem to be a compelling reason for sleep deprivation.

Read More

Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany

RHEINFELDEN, Germany, March 16, 2018 /PRNewswire/ -- Thermo Fisher Scientific announced today it is expanding its footprint in the European Union and investing $35 million in a state-of-the-art pharma services supply chain facility in Rheinfelden (Baden) Germany. Company representatives joined Mayor Eberhardt at the Rheinfelden council meeting to unveil the details of the project earlier today.

The new facility will leverage the latest technology and modern infrastructure to significantly increase European capacity for cold and ambient clinical trial materials in support of complex clinical research and so meet the growing needs of customers. The facility will be scalable for mixed-use space and provide a strategic logistical location for shipping either by road or air.

Mayor Eberhardt acknowledged local support for the project stating, "We are looking forward to partnering with Thermo Fisher Scientific to bring this new facility to life in our community which will create significant opportunity for jobs in the expanding life sciences segment. We are confident their investment will benefit our local economy and create greater opportunities for our citizens."

The company expects to start construction in Q4' 2018 for the 8,000 square meter facility at the 26,000 square meter site with an anticipated completion within 12 to 18 months. Once complete, this new facility will provide up to 200 new jobs locally. The investment includes the option for additional expansion with the potential for doubling the footprint.

"This is an exciting time for our business, and it reinforces our commitment to best serve our clients globally. By creating a best-in-class supply chain facility in the EU, we open new opportunities to support client and patient need," said Astrid Frank, Vice President and General Manager, Europe, Fisher Clinical Services. 

The company's decision to expand is in response to a growing demand for global clinical supply services, worldwide. The new facility will also serve to address GDP guidelines, Clinical Trial Regulations Annex 6 and the new Falsified Medicines Directive 2019. This GMP/GDP facility builds on the company's existing footprint of 20 purpose-built cGMP facilities globally.                          

Thermo Fisher's Pharma Services develops unique solutions and business models to help customers manage the clinical development process and provides flexible manufacturing options to address client needs in an evolving marketplace.

Read More

DaVita Kidney Care Recognizes Its Dietitians on Registered Dietitian Nutritionist Day

DENVER, March 14, 2018 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States, honors Registered Dietitian Nutritionist Day by recognizing its more than 2,000 registered dietitians across the U.S. and in 11 countries around the world.

"We celebrate National Nutrition Month^® and National Registered Dietitian Nutritionist Day in March. This special time is to honor the professional passion and dedication of dietitians and the impact they have on individuals' overall health and well-being," said Debbie Benner, vice president of clinical support for DaVita Kidney Care. "Dietitians use the science of nutrition to enable people to make personalized, positive lifestyle changes. This is especially true for patients with chronic diseases such as kidney disease, diabetes and hypertension."

DaVita dietitians, who are renal nutrition experts, work with patients to help them achieve:

• Better nutritional status, by assessing nutritional intake and biochemical parameters. For example, they provide individualized meal plans based on patients' unique needs and preferences.
• Mineral and bone disorder management through education that considers disease state, laboratory results, medications and dietary aspects.
• Fluid balance, by providing easy-to-follow tips to help manage sodium and fluid intake. Dietitians also offer suggestions for healthy, flavorful alternatives to high sodium foods.

"DaVita's focus is on the individual and their unique needs," said Allen R. Nissenson, M.D., FACP, chief medical officer for DaVita Kidney Care. "Our dietitians lead this effort by listening to each patient's preferences, considering cultural aspects and then guiding patients to make lifestyle choices that can positively impact their overall health and well-being."

DaVita dietitians are trained extensively in motivational interviewing. This skill enhances their ability to engage patients and positively influences their ability to reach their personal health goals.

For more information about a kidney-friendly diet, visit the DaVita^® Kidney Diet Tips blog at Blogs.DaVita.com.

Read More